Core Viewpoint - Oragenics, Inc. has announced a One-for-Thirty reverse stock split to enhance its capital market presence and align with long-term investors' expectations [1][4]. Group 1: Reverse Stock Split Details - The reverse stock split will combine every 30 pre-split shares into one new share, effective at 12:01 a.m. Eastern Time on June 3, 2025 [2][3]. - Fractional shares resulting from the split will be rounded up to the nearest whole share for each shareholder [2]. - The split will not affect the par value of the common stock or the number of authorized but unissued shares [2][3]. Group 2: Company Strategy and Leadership Comments - The CEO, Ms. Janet Huffman, emphasized that the reverse split is aimed at strengthening the company's capital markets presence and attracting quality-focused investors [4]. - The company believes that increasing the share price and reducing share count will better align with investor expectations [4]. Group 3: Company Overview - Oragenics is a clinical-stage biotechnology company focused on developing innovative treatments for neurological disorders, with its lead asset being ONP-002, an intranasal therapy for concussion treatment [5].

Company Overview - Taoping Inc. is a provider of innovative smart cloud platform services and solutions, focusing on technology to enhance communication and marketing for both private and public sectors [4]. Reverse Stock Split Announcement - The board of directors approved a one-for-thirty reverse stock split of the Company's issued and outstanding ordinary shares, effective May 29, 2025 [1]. - Each thirty ordinary shares will automatically combine into one issued and outstanding ordinary share without requiring action from shareholders [2]. Purpose of the Reverse Stock Split - The reverse stock split aims to increase the per share trading price to meet the $1.00 minimum bid price requirement for continued listing on the Nasdaq Stock Market [3]. - Post-split, the Company will have approximately 0.89 million ordinary shares issued and outstanding, excluding shares from options and convertible notes [3].

Core Points - Vaxart, Inc. has adjourned its 2025 annual meeting of stockholders to June 2, 2025, at 8:30 a.m. Pacific Time [1] - The meeting will be held in a virtual-only format, accessible via a specific website [2] - Stockholders who have not yet voted are encouraged to do so by June 1, 2025, at 11:59 p.m. Eastern Time [4] Company Overview - Vaxart is a clinical-stage biotechnology company focused on developing oral recombinant vaccines using a proprietary delivery platform [6] - The company's vaccines are designed to be administered in pill form, eliminating the need for refrigeration and reducing the risk of needle-stick injuries [6] - Current development programs include vaccines for coronavirus, norovirus, influenza, and a therapeutic vaccine for human papillomavirus (HPV) [6]

Core Points - Ekso Bionics Holdings, Inc. will implement a reverse stock split at a ratio of 1-for-15, effective May 27, 2025 [1][3] - The number of outstanding shares will decrease from approximately 35,289,695 to about 2,352,646 post-split [2] - The reverse stock split aims to raise the per share trading price to comply with Nasdaq's minimum bid price requirement of $1.00 for ten consecutive trading days [3] Shareholder Impact - No fractional shares will be issued; any fractional shares will be rounded up to the next whole share [4] - The reverse stock split will uniformly affect all shareholders without significantly altering their percentage interest in the company's equity [5] - Stock options and restricted stock units will be adjusted accordingly, with a corresponding increase in exercise prices [5] Administrative Details - Shareholders holding shares electronically will not need to take action as their shares will be automatically adjusted [6] - Shareholders with physical certificates can contact VStock Transfer, LLC for information on exchanging their certificates [6] - Additional information regarding the reverse stock split is available in the Company's Definitive Proxy Statement filed with the SEC [6] Company Overview - Ekso Bionics is a leading developer of exoskeleton solutions aimed at enhancing human strength, endurance, and mobility in medical and industrial applications [7] - The company focuses on improving health and quality of life through advanced robotics designed to restore human function [7] - Ekso Bionics is headquartered in the San Francisco Bay Area and is listed on the Nasdaq Capital Market under the symbol "EKSO" [7]

Core Viewpoint - Bon Natural Life Limited will implement a 1-for-25 reverse stock split to comply with Nasdaq's minimum bid price requirement of $1.00, effective May 19, 2025 [3]. Group 1: Reverse Stock Split Details - The reverse stock split will convert every 25 issued and outstanding Class A ordinary shares into one new Class A ordinary share, with no fractional shares issued [1]. - The new CUSIP number for the Class A ordinary shares post-split will be G14492204, and trading will continue under the existing symbol "BON" [2]. - The authorized share capital will increase to 1,000,000,000 Class A ordinary shares, 50,000,000 Class B ordinary shares, and 50,000,000 preference shares [4]. Group 2: Class Rights and Shareholder Approval - The conversion rate for Class B ordinary shares will change from a 1:1 basis to a 1:25 basis for conversion into Class A ordinary shares [5]. - The reverse stock split and related changes were approved by shareholders during an extraordinary general meeting on April 15, 2025 [6].

Core Viewpoint - Presidio Property Trust, Inc. will implement a 1-for-10 reverse stock split of its Series A Common Stock to comply with Nasdaq listing requirements [1][2][3] Group 1: Reverse Stock Split Details - The reverse stock split will take effect on May 19, 2025, with shares trading under the symbol "SQFT" and a new CUSIP number 74102L501 [2] - Every 10 shares of Series A Common Stock will be combined into 1 share, maintaining the same percentage ownership for stockholders, with adjustments for fractional shares [3] - Fractional shares will not be issued; instead, stockholders will receive an additional fraction of a share to round up to the nearest whole share [3] Group 2: Company Overview - Presidio is an internally managed real estate investment trust with a diversified portfolio including model home properties leased to homebuilders, as well as office, industrial, and retail properties [5] - The company's model homes are primarily located in the sunbelt region, while its other properties are mainly situated in Colorado, with additional locations in Maryland, North Dakota, Texas, and Southern California [5]

Core Points - Altisource Portfolio Solutions S.A. announced a reverse stock split approved by shareholders, consolidating every eight shares into one, reducing outstanding shares from approximately 88.95 million to about 11.12 million [1][2] - The reverse stock split is set to take effect on May 28, 2025, following necessary administrative procedures [2] - Shareholders must hold shares in multiples of eight by market close on May 27, 2025, to avoid receiving cash for fractional shares [3][4] - Fractional shares will be redeemed for cash at the closing price on May 27, 2025, and proceeds will be distributed pro rata without interest [3][4] - The consolidation aims to help the company comply with Nasdaq's minimum bid price requirement of $1.00 [5] Share Consolidation Details - The reverse stock split will reduce the total number of outstanding shares significantly, which is a strategic move to enhance the company's stock price [2][5] - The company has filed a definitive proxy statement with the U.S. Securities and Exchange Commission detailing the rationale and effects of the share consolidation [5] Shareholder Actions - Shareholders are encouraged to check with their financial intermediaries to ensure their holdings are in amounts divisible by eight to avoid cash-out for fractional shares [4] - The company will handle fractional shares by redeeming them for cash, ensuring that shareholders are informed of the process [3][4]

Core Viewpoint - Stock splits can indicate a company's performance, with forward splits often seen positively, while reverse splits may signal struggles, as exemplified by Tilray Brands [1][2][4]. Group 1: Stock Splits - A forward stock split increases the number of shares for each investor, often indicating expected strong performance and making shares more affordable [2]. - A reverse stock split reduces the number of shares and increases the stock price proportionately, often used to avoid delisting from major exchanges [2][3]. Group 2: Tilray's Performance - Tilray has faced significant challenges, with its share price dropping below $1, currently at approximately $0.43, indicating a long-term downward trend [4]. - The company's financial results are disappointing, with revenue growth largely driven by acquisitions and consistent unprofitability [4][6]. - The legal landscape for cannabis remains difficult, with federal illegality in the U.S. and regulatory barriers in Canada hindering growth [6]. Group 3: Reverse Stock Split Proposal - Tilray announced a special stockholders' meeting to vote on a reverse stock split proposal, which is likely to be approved given the company's current situation [7]. - A reverse stock split would prevent delisting from Nasdaq but does not address the underlying business challenges [8]. Group 4: Future Prospects - Tilray has reduced its focus on cannabis and is now a leading craft brewer in the U.S., hoping for future federal legalization of cannabis [8]. - CEO Irwin Simon anticipates potential legalization during President Trump's second term, which could position Tilray favorably in the cannabis-infused drinks market [9]. - However, uncertainties remain regarding the timeline and specifics of legalization, which could limit market potential [9][10]. Group 5: Investment Outlook - Given the ongoing challenges and lack of attractive business prospects, Tilray is not considered an appealing investment opportunity [10].

Core Viewpoint - Caliber will implement a 1-for-20 reverse stock split of its Class A and Class B common stock effective May 2, 2025, to comply with Nasdaq's minimum bid price requirement of $1.00 [1][2][3] Group 1: Reverse Stock Split Details - The reverse stock split will convert twenty current shares into one issued and outstanding share, without changing the par value or the authorized number of shares [4] - Approximately 18,574,292 shares of Class A Common Stock and 7,416,414 shares of Class B Common Stock will be reduced to approximately 928,715 shares of Class A and 370,821 shares of Class B after the split [5] - No fractional shares will be issued; all fractional shares will be rounded up to the nearest whole share [5] Group 2: Stockholder Information - Registered stockholders holding pre-split shares electronically will not need to take action to receive post-split shares, while those holding shares via brokers will have their positions automatically adjusted [6] - The reverse stock split was approved by stockholders at a special meeting on April 21, 2025, with the board of directors deciding on the 1-for-20 ratio [3] Group 3: Company Overview - Caliber manages over $2.9 billion in assets and specializes in hospitality, multi-family residential, and multi-tenant industrial sectors [7] - The company aims to generate returns in all market conditions and focuses on investment opportunities often overlooked by global real estate institutions [7]

Core Points - Snow Lake Resources Ltd. will implement a 1-for-13 reverse stock split effective on May 2, 2025, to comply with Nasdaq's minimum bid price requirement of $1.00 [1][2] - The reverse stock split will reduce the number of issued and outstanding common shares from approximately 101,704,516 to about 7,823,360 [4] - The reverse stock split will not change the par value of the common shares or the authorized number of shares, and it will affect all shareholders uniformly [3][4] Company Information - Snow Lake Resources Ltd., operating as Snow Lake Energy, is a Canadian mineral exploration company listed on Nasdaq under the symbol LITM, focusing on critical mineral and clean energy projects [8] - The company has exploration stage projects including the Pine Ridge Uranium project in Wyoming, USA, and the Engo Valley Uranium Project in Namibia, along with additional projects in Manitoba [8]